Robert Forrester's insider trading activity shows a notable pattern from 2019 to 2021. He made significant trades monthly, with peaks like $964.29K in June 2021, indicating a strong belief in Verastem's trajectory at that time. In his last months at...

Robert Forrester's insider trading activity shows a notable pattern from 2019 to 2021. He made significant trades monthly, with peaks like $964.29K in June 2021, indicating a strong belief in Verastem's trajectory at that time. In his last months at Verastem, his investments seemed to reflect confidence, likely fueled by the company's progress on key clinical targets. By January 2022, the values began to decline, with smaller transaction amounts indicating a shift in strategy. The fluctuating values highlight his strategic moves as a major player both in terms of holding company shares and making significant trades to leverage changes in the market. Overall, his holdings tell a story of an active investor closely tied to Verastem's development.